This invention relates to a new pharmaceutical composition for treatment of infective Endocarditis. The present invention generally relates to the fields of bacteriology and infectious diseases. This invention relates to the novel method of inhibiting, preventing or treating bacterial infections. The present invention relates to the inhibition of virulence factor of bacteria and thereby reduction of its virulence. More specifically, it relates to inhibitors of certain bacterial mechanisms and bacterial infection treatments using these inhibitors. The present embodiment discloses a novel compound (4-carbamoyl-5-hydroxy-6-iodo-13 -iodinin-2-yl) sodium, act has an inhibitor for the GspB.
展开▼
